Plan B, the emergency contraceptive rejected for over-the-counter sales by the FDA in May, has reapplied after limiting sales to those 16 years of age and older.
Concern about sales of the contraceptive to young teens was the FDA's putative reason for rejecting Plan B, despite the overwhelming support for the medicine from FDA's scientific panel. Many observers believe that the FDA's director bowed to pressure from the anti-abortion movement and its allies in the Bush administration.
But Plan B is likely to slash the number of abortions. As the PI article reports:
James Trussell, director of Princeton University's Office of Population Research . . . has concluded that easy access to emergency contraception could cut by half the number of unintended pregnancies and abortions among U.S. women, ages 15 to 44.